Skip to main content
OpenTrials
Completed

NCT Number: NCT01133938

Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip

Several risk factors for the development of osteonecrosis of the femoral head following treatment of developmental dislocated hip have been reported. The need for further research with a large-enough sample size including statistical adjustment of confounders was demanded. The purpose of the present study was to find reliable predictors of osteonecrosis in patients managed for developmental dislocation of the hip and to evaluate if delayed treatment increased the risk of residual acetabular dysplasia requiring secondary surgeries.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Predictors of Osteonecrosis of the Femoral Head After Treatment of the Dislocated Hip

Age range

1 month–15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Orthopedic Hospital Vienna Speising

Vienna, State of Vienna, 1130, Austria

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Follow-up > 3 years

Exclusion criteria

  • teratological hip dislocation
  • neuromuscular disease
  • previous open reduction at another medical institution

Treatment and study plan

Primary outcomes

  1. Osteonecrosis of the femoral head

Secondary outcomes

  1. Secondary reconstructive procedures due to residual acetabular dysplasia

Sponsors and collaborators

Lead sponsor

Orthopedic Hospital Vienna Speising

Other

Registry information

Official study title

Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
May 31, 2010
Registry last updated
Jun 3, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.